Business Wire

MODULEX

5.5.2022 15:02:06 CEST | Business Wire | Pressemeddelelse

Del
Modulex A/S med hovedkontor i Billund afsluttede 2021 med et økonomisk godt resultat på trods af endnu et udfordrende pandemiår.

Modulex A/S er globalt markedsledende inden for visuel kommunikation med 30 salgsenheder og flere produktionsfaciliteter rundt omkring i verden. Modulex A/S leverer wayfinding og arkitektoniske skilteløsninger samt multi-site brandimplementering og er den førende producent af systemskilte på verdensplan.

Koncernen sluttede 2021 med et EBITDA resultat på 17 mio. kr.

Mens koncernen som helhed leverede et flot resultat, er flere salgsenheder som fx Modulex Hospitality, der primært leverer skilteløsninger til internationale hotelkæder og ferieresorts, fortsat alvorligt påvirket af den globale pandemi og er først begyndt at se tegn på opsving i år. På trods af at det mange steder stadig er vanskeligt fysisk at besøge projekter og kunder, holdt de lokale kontorer verden over fast. Globalt set har Modulex Gruppen haft det bedste år i koncernens historie og har i løbet af året leveret og implementeret nogle meget store virksomhedsrebrands i både USA og Vesteuropa.

”Set i lyset af det pres, vi oplever på leveringstider og råmaterialer som aluminium, er vores resultat meget flot," siger Ketil M. Staalesen, administrerende direktør og hovedaktionær i Modulex Gruppen. "Vores produktionsteam udnyttede partnerskaber etableret gennem mange års samarbejde til at sikre, at vi kunne imødekomme vores kunders krav. Vores forretningsudviklingsstrategi fokuserede på at fremme miljøvenlige produkter som Etronit og Greenbond™, som er mindre påvirket af leveringsmæssige udfordringer."

Modulex Gruppen vil i 2022 fokusere på design-build-strategien, globale kunder, mere miljøvenlige produkter og lanceringen af ​​den cloud-baserede projektstyringssoftware e-Modulex. Modulex har allerede indgået nye.

"2022 bliver stadig en udfordring," siger Staalesen. “Men vores solide forretningsstrategi og vores ledelsesteams evne til at kæmpe gennem de seneste to år inspirerer mig. Jeg kunne ikke være mere stolt af dem, og jeg forventer, at vi overgår vores forventninger i år."

www.modulex.com

Om Modulex Gruppen:

Modulex Gruppen, som blev grundlagt i 1963 af LEGO-koncernen og som siden 2009 har været ejet af ledelsen samt andre eksterne investorer, er global markedsleder inden for visuel kommunikation og brandimplementering. Med rod i dansk designekscellence og et modulært skiltekoncept har Modulex udviklet sin platform yderligere med design, wayfinding, brugerdefinerede løsninger og brandimplementeringer. Fabrikken i Billund, som er ISO 9001-certificeret, lancerede i 2019 en mere miljøvenlig produktlinje. Modulex Billund blev tildelt Green Network-diplomet for niende år i træk. Modulex Gruppen har fem fabrikker globalt. Koncernen er repræsenteret i over 300 byer på tværs af 45 lande, hvilket giver Modulex Gruppen den nødvendige rækkevidde og evne til at leve op til sit løfte om global vision, lokal rækkevidde og én virksomhed.

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release

Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye